We characterized a novel neurodegenerative disease, neuronal loss, and parkinsonism driven by PRKAR1B mutation (NLPD‐PKA), demonstrating disrupted holoenzyme assembly, reduced cooperativity, and increased catalytic subunit nuclear translocation, altering gene expression in patient‐derived cells. The gene discussed is PRKAR1B; the disease is neurodegenerative disease.